Last week, the bipartisan Modernizing Opioid Treatment Access Act 2.0 was reintroduced by Senator Markey. AAPP is among the over 50 organizations who have endorsed the legislation which would improve patients’ access to treatment for opioid use disorder (OUD) by empowering board-certified physicians to prescribe, and pharmacies to dispense, methadone for OUD. While physicians can prescribe, and pharmacies can dispense, methadone for pain, methadone for OUD is only available at opioid treatment programs (OTPs). Patients usually have to travel to an OTP every day, or almost every day, especially early in their treatment. OTPs can be difficult to access, particularly in rural areas and for individuals with limited access to transportation. On average, patients would need to drive 4.5 times farther to get to an OTP compared to a pharmacy. Canada, the UK, and Australia allow for methadone prescribing outside of specialty treatment settings and for pharmacies to dispense methadone.